CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
Income Statement [Abstract] | ||||
Revenue | $ 919,304 | $ 1,313,873 | $ 1,332,616 | $ 3,411,102 |
Cost of goods sold | 295,475 | 390,251 | 303,646 | 1,435,690 |
Gross Profit | 623,829 | 923,622 | 1,028,970 | 1,975,412 |
Operating Expenses: | ||||
Impairment loss | 3,505,069 | 2,117,502 | ||
General and administrative expenses | 245,420 | 345,904 | 267,008 | 654,516 |
Compensation expense | 236,837 | 1,156,998 | 1,068,957 | 2,057,472 |
Professional fees | 23,212 | 52,901 | 283,487 | 388,159 |
Total operating expenses | 505,469 | 1,555,803 | 5,124,521 | 5,217,649 |
Gain (loss) from operations | 118,360 | (632,181) | (4,095,551) | (3,242,237) |
Other income (expense): | ||||
Gain on disposal | 11,233,944 | |||
Derivative: expense, gains and losses from issuances | (33,133) | (4,108,977) | (175,495) | (20,722,300) |
Changes in fair value of derivatives | 1,702,515 | 3,718,424 | 1,767,895 | 13,136,512 |
Gain on deconsolidation of accounting acquirer | 1,170,433 | |||
Interest expense | (346,278) | (434,779) | (636,679) | (822,630) |
Loss on conversion of convertible debt | (150,983) | (179,921) | (262,456) | (179,921) |
Total other income (expense) | 1,172,121 | (1,005,253) | 11,927,209 | (7,417,906) |
Income (loss) before provision for income tax | 1,290,481 | (1,637,434) | 7,831,658 | (10,660,143) |
Provision for income tax | ||||
Net income (loss) | $ 1,290,481 | $ (1,637,434) | $ 7,831,658 | $ (10,660,143) |
Basic income (loss) per share | $ 0.00 | $ (0.00) | $ 0.02 | $ (0.03) |
Diluted income (loss) per share | $ 0.00 | $ (0.00) | $ 0.00 | $ (0.03) |
Basic weighted average shares | 550,554,328 | 367,173,274 | 472,202,571 | 360,213,016 |
Diluted weighted average shares | 11,483,557,124 | 367,173,274 | 11,405,205,367 | 360,213,016 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|